Cargando…
Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis
Cyclophosphamide (cy) is an alkylating agent used to treat malignancies and immune-mediated inflammatory nonmalignant processes. It has been used as a treatment in cases of worsening multiple sclerosis (MS). Cy is currently used for patients whose disease is not controlled by beta-interferon or glat...
Autores principales: | Patti, Francesco, Lo Fermo, Salvatore |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087413/ https://www.ncbi.nlm.nih.gov/pubmed/21547093 http://dx.doi.org/10.4061/2011/961702 |
Ejemplares similares
-
Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
por: Zanghì, Aurora, et al.
Publicado: (2021) -
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective
por: Toscano, Simona, et al.
Publicado: (2023) -
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies
por: Sgarlata, Eleonora, et al.
Publicado: (2022) -
Negative prognostic impact of MRI spinal lesions in the early stages of relapsing–remitting multiple sclerosis
por: D’Amico, E, et al.
Publicado: (2016) -
Pharmacologicaltreatment of COVID-19: lights and shadows
por: Menzella, Francesco, et al.
Publicado: (2020)